drugset / Trial / NCT01321047
Balanced Propofol Sedation Versus Propofol Alone Sedation in Therapeutic Endoscopic Retrograde Cholangiopancreatography (ERCP)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Based on previous results, the investigators considered that sedation quality, complications, and procedure outcomes may not be different, however, propofol alone titration may have a fast recovery time than BPS and cost-effectiveness than balanced propofol sedation (BPS). In present study, the investigators therefore evaluate the time and sedation quality of patient recovery, cost-effectiveness, complication, and procedure outcomes between propofol alone and BPS in therapeutic endoscopic retrograde cholangiopancreatography (ERCP).
Timeline
- Start
- 2011-04
- Primary completion
- 2011-09
- Completion
- 2011-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fentanyl | Other / unclassified | 25 ug | Intravenous |
| Subject | Fentanyl | Other / unclassified | 50 ug | Intravenous |
| Subject | Midazolam | Small molecule | 0.05 mg/kg | Intravenous |
| Subject | Midazolam | Small molecule | 1 mg | Intravenous |
| Comparator | Propofol | Small molecule | 0.5 mg/kg | Intravenous |
| Comparator | Propofol | Small molecule | 10 mg | Intravenous |
Indications
No indication recorded.